Baxter and Hillrom - Destined to Transform

Healthcare professionals wearing masks have a discussion around a conference table

Hillrom is a part of Baxter

Baxter and Hillrom are uniting to meet the challenges of a rapidly evolving healthcare landscape. Together, we are focused on transforming healthcare with bold innovations that will help us realize our shared promise to improve care for all. We invite you to stay informed of our integration progress by visiting Baxter.com.

At Baxter, We’re All In. All Ways.

With ongoing investments in world-class manufacturing, meaningful innovations and a focus on patient safety, Baxter prioritizes patients and healthcare providers by ensuring that innovative treatment, solutions and support are available to help enhance safety and improve patient care. At Baxter, we're All In. All Ways.

Baxter’s commitment to saving and sustaining lives has grown to impact many areas of healthcare. With ongoing investments in world-class manufacturing, meaningful innovations and a focus on patient safety, Baxter prioritizes patients and healthcare providers by ensuring that innovative treatment, solutions and support are available to help enhance safety and improve patient care. We’re All In. All Ways.

Learn more about Vancomycin Injection

Expanding Premix Portfolio:
Additional Options of Vancomycin Injection, USP in 5% Dextrose

Learn more about Vancomycin Injection
Learn more about Vasopressin in 0.9% Sodium Chloride Injection

Expanding Portfolio:
First and only premix in a flexible GALAXY bag
Vasopressin in 0.9% Sodium Chloride Injection.

Learn more about Vasopressin in 0.9% Sodium Chloride Injection
 Adaptobility: The First and Only Frozen Premix Daptomycin in 0.9% Sodium Chloride Injection

Expanding Premix Portfolio:
The First and Only premix Daptomycin in 0.9% Sodium Chloride Injection

Learn more about Daptomycin premix
Norepinephrine Bitartrate in 5% Dextrose Injection

Expanding Premix Portfolio:
Norepinephrine Bitartrate in 5% Dextrose Injection

Learn more about Norepinephrine
A Homecoming: Frozen Premix  ZOSYN (piperacillin and tazobactam) injection is only made by Baxter and is Available with one point of contact for our customers.

Expanding Premix Portfolio:
ZOSYN (piperacillin and tazobactam) Injection is only made by Baxter and is available with one point of contact for our customers.

Learn more about Zosyn premix

Partnering with You to Help Solve Today’s Challenges

 

A retrospective study estimated there are 1.2 million hospitalizations with preventable adverse drug events (ADE) related to injectable medications. Incremental cost of all preventable ADEs is estimated to be $3.8 billion annually.1

 

A retrospective study to assess the impact of the drug delivery system on the odds of bloodstream infection (BSI) showed a 12% reduction in odds of BSI with closed systems.2

 

Intravenous medication preparation is a complex process, with 30% of hospitals experiencing a patient event involving a compounding error over a five-year period.3

Partnering for Better Outcomes from the Bedside to the Pharmacy

Male doctor talking to a male patient lying in a hospital bed

For more than 90 years, Baxter has been saving and sustaining lives. We take pride in our ability to help maximize the quality, safety, and ease of use of our products and medications, while minimizing costs, all in pursuit of helping you achieve the best outcomes for your patients.

Where You Need Us Most in the Healthcare System

Contributing to Peace of Mind

Close up on a hospital pharmacist's face with scrubs and hair covered

Our robust manufacturing and distribution network helps ensure continuity of supply to contribute to peace of mind for clinicians that they will have product when it’s needed.

Our worldwide manufacturing footprint allows us to source quality medical products for the U.S.

 

Our IV solutions facility in North Cove, NC, manufactures more than 125 different solutions.

 

Our IV solutions plant in Puerto Rico is one of the largest IV solutions manufacturing facilities in the world.

 

We increased U.S. capacity through our extensive global manufacturing operations in 2018.

For Medical Information, please access US Medical Information On-line.